Long-term safety and outcome of subcutaneous and intravenous treprostinil in patients with severe chronic pulmonary hypertension Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019
Low-dose amiodarone therapy may be responsible of serious adverse pulmonary effects in patients without pre-existing lung disease Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004
Uncoupling in airway reactivity between in vitro exposure to meconium and meconium aspiration and effect of dexamethasone Source: Eur Respir J 2006; 28: Suppl. 50, 705s Year: 2006
Combination therapy in severe pulmonary hypertension with bosentan and treprostinil: successful switch from subcutaneous to intravenous application Source: Eur Respir J 2006; 28: Suppl. 50, 384s Year: 2006
Pentoxifylline and reduced doses of steroids combination in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007
Long-term efficacy and safety of N-acetylcysteine inhalation in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009
Early administrations of dexamethasone, n-acetylcysteine and aprotinin have beneficial effects on inflammatory and oxidant-antioxidant status after lung contusion in rats Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Comparison of two regimens of oral anticoagulation in pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006
Instillation of surfactant-BL is more effective than aerosol administration in treatment of premature newborns with severe RDS Source: Eur Respir J 2002; 20: Suppl. 38, 532s Year: 2002
Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001
Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020
A comparison of the effects of lung function between low dose theophylline and oral β2-agonist in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 215s Year: 2006
Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with pulmonary infections Source: Eur Respir J 2006; 28: Suppl. 50, 275s Year: 2006
Long-term treatment of pulmonary hypertension with aerosolized iloprost Source: Eur Respir J 2001; 17: 8-13 Year: 2001
Low dose intravenous iloprost therapy in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 426s Year: 2006
N-acetylcysteine potentiates surfactant therapy for experimental meconium aspiration syndrome Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Source: Eur Respir J 2001; 17: 337-342 Year: 2001
Tracheal instillation of dexamethasone for the treatment of chronic lung disease in premature infants Source: Eur Respir J 2005; 26: Suppl. 49, 392s Year: 2005
Intravenous iloprost as "rescue therapy" in patients with severe primary pulmonary hypertension deteriorating while on chronic aerosolized iloprost therapy Source: Eur Respir J 2004; 24: Suppl. 48, 705s Year: 2004
Comparison of efficacy of intravenous and inhaled magnesium sulphate as an adjunct to standard therapy in acute severe asthma Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma Year: 2008